BPIQ-AI · October–November 2026 Report
PDUFA Probability
& Move Analysis
If you invest in smid-cap biopharma, these upcoming FDA decisions need to be on your radar. Get BPIQ-AI's probability and stock move analysis for every Oct–Nov PDUFA, free.
Probability and move ranges:
AI-predicted probability and price-move ranges for 16 upcoming October–November PDUFA decisions, across three outcomes (Clean+, Mixed, Clean−)
CMC and regulatory risk:
flags for manufacturing (CMC) and regulatory risk that could derail an approval, plus a red/yellow/green hedge fund risk rating
Big Mover flags:
BM when both our model and options data point to a 20%+ move, SBM (Suspected Big Mover) when our model shows 20%+ but options don't confirm it
Clean+ is a market-outcome probability, not simply the chance a company calls its results 'positive.'
Data as of September 23, 2026 · Powered by BPIQ-AI, options and hedge fund data
For informational purposes only. This is NOT investment advice. Our models are still being refined. Use this as one part of your own research, or consult a registered professional before trading.
Get the Full Oct-Nov
PDUFA Table Now!
See what BPIQ users are saying
Get Biotech Stocks To Watch Delivered To You Instantly
What’s inside the report?
STOCKS TO WATCH
Get stocks that are showing high volatility, poised to move.
CATALYST DETAILS
See the drug, date, and more details about each event.
DEEPER ANALYSIS
Get deeper insights into a few stocks catalyst event.
VARIETY OF INDICATIONS
These stocks are in a range of indications allowing you to find opportunities that fit your criteria.